Group 1 - The company, TeBao Bio, announced its participation in the 2025 semi-annual performance briefing for the biopharmaceutical and CXO industry on September 15, 2025, from 15:00 to 17:00 [2]

Group 1 - The company, Nawei Technology, announced plans to hold a collective performance briefing for the biopharmaceutical and CXO industry on September 15, 2025, from 15:00 to 17:00 [1]

Group 1 - The company announced its participation in the 2025 semi-annual performance briefing for the biopharmaceutical and CXO industry on September 15, 2025, from 15:00 to 17:00 [2]

Core Viewpoint - The company, Jia Bi You, announced its participation in the 2025 semi-annual performance briefing for the bioproducts and CXO industry, organized by the Shanghai Stock Exchange, scheduled for September 15, 2025, from 15:00 to 17:00 [2] Group 1 - The company plans to attend a collective performance briefing [2] - The event is focused on the bioproducts and CXO industry [2] - The briefing is organized by the Shanghai Stock Exchange [2]

Core Viewpoint - The company, Amoytop Biopharmaceuticals Co., Ltd., is holding a performance briefing on September 15, 2025, to discuss its 2025 semi-annual financial results and operational performance with investors [1][2]. Group 1: Meeting Details - The performance briefing is scheduled for September 15, 2025, from 15:00 to 17:00 [2][3]. - The meeting will take place at the Shanghai Stock Exchange Roadshow Center and will be conducted in an interactive online format [2][3]. - Investors can submit questions from September 8 to September 12, 2025, through the Roadshow Center website or via the company's email [3]. Group 2: Participants - Key participants in the meeting will include the company's Chairman and General Manager, Mr. Sun Li, and the Vice General Manager and Financial Director, Ms. Yang Yiling, along with independent director Mr. Liu Qi [2]. Group 3: Investor Participation - Investors can participate in the performance briefing by logging into the Shanghai Stock Exchange Roadshow Center on the scheduled date and time [2][3]. - The company will address commonly asked questions during the briefing [2][3]. Group 4: Contact Information - For inquiries, investors can contact the Board Office at phone number 0592-6889118 or via email at ir@amoytop.com [3].

Core Points - The company will hold a collective performance briefing for the bioproducts and CXO industry on September 15, 2025, from 15:00 to 17:00 [1][2] - The briefing will be conducted online through the Shanghai Stock Exchange Roadshow Center, allowing for interactive text communication [2][3] - Investors can submit questions in advance from September 8 to September 12, 2025, to be addressed during the event [3] Meeting Details - Meeting Date and Time: September 15, 2025, from 15:00 to 17:00 [2] - Meeting Location: Shanghai Stock Exchange Roadshow Center (https://roadshow.sseinfo.com/) [2] - Meeting Format: Online text interaction [2] Participants - Key attendees include Dr. Jiang Biwang (Chairman), Mr. Zhao Shun (Board Secretary and CFO), Professor Wu Anping (Independent Director), and Ms. Ma Jiahui (Securities Affairs Representative) [2] Investor Participation - Investors can participate online during the meeting and will receive timely responses to their questions [2][3] - Contact information for inquiries includes the Securities Affairs Department, phone: 0512-62956018, and email: ir@nanomicro.com [3]

Group 1 - The company, Shanghai Haohai Biological Technology Co., Ltd., will participate in the 2025 semi-annual performance briefing for the biopharmaceutical and CXO industry organized by the Shanghai Stock Exchange to enhance communication with investors [1][2] - The performance briefing is scheduled for September 15, 2025, from 15:00 to 17:00, and will be conducted via video live streaming and online interaction [1][2] - Investors are encouraged to submit questions from September 8 to September 12, 2025, through the Shanghai Stock Exchange Roadshow Center website or via the company's email [2] Group 2 - Key participants in the briefing will include the company's chairman, general manager, financial officer, independent directors, and the board secretary, although adjustments may occur due to special circumstances [2] - After the briefing, investors can access the main content and details of the event through the Shanghai Stock Exchange Roadshow Center [2]

Group 1 - The company will hold a performance briefing for the first half of 2025 on September 15, 2025, from 15:00 to 17:00 [1][2] - The meeting will take place at the Shanghai Stock Exchange Roadshow Center and will be conducted in an online text interaction format [1][2] - Investors can submit questions from September 8 to September 12, 2025, through the Roadshow Center website or via the company's email [1][3] Group 2 - Key personnel attending the meeting include the Chairman and General Manager, Yi Dewei, and the Financial Director, Wang Huabiao [2] - The company aims to address common investor concerns regarding its operational results and financial indicators during the briefing [2][3] - After the meeting, investors can access the main content and outcomes of the briefing on the Roadshow Center website [3]

Core Viewpoint - The company will participate in the 2025 semi-annual performance briefing for the biopharmaceutical and CXO industry on September 15, 2025, to address investor concerns and discuss its operational results and financial status for the first half of 2025 [1][2]. Group 1: Meeting Details - The meeting is scheduled for September 15, 2025, from 15:00 to 17:00 [2][3]. - The location of the meeting is the Shanghai Stock Exchange Roadshow Center, accessible via the website: http://roadshow.sseinfo.com/ [2][3]. - The format of the meeting will be an online interactive session [2][3]. Group 2: Participation Information - Investors can participate in the meeting by logging into the Shanghai Stock Exchange Roadshow Center on the scheduled date [3]. - Investors are encouraged to submit questions from September 8 to September 12, 2025, before 16:00, either through the Roadshow Center's "Pre-Question Collection" section or via the company's email [3]. - The company will respond to commonly asked questions during the briefing [3]. Group 3: Attendees - Key attendees include the Chairman Ye Jun, General Manager Guo Mingjie, Vice General Manager and Financial Officer Wu Yiming, Vice General Manager and Board Secretary Li Fangli, and Independent Director Liu Zhijie [2].

Group 1 - The company will hold a performance briefing on September 15, 2025, from 15:00 to 17:00 [2][3] - The briefing will take place at the Shanghai Stock Exchange Roadshow Center and will be conducted in an online interactive format [2][3] - Key company personnel, including the chairman and financial director, will participate in the briefing [2][3] Group 2 - Investors can submit questions for the briefing from September 8 to September 12, 2025, before 16:00 [3] - The company will address commonly asked questions during the briefing [2][3] - After the briefing, investors can access the main content and outcomes through the Shanghai Stock Exchange Roadshow Center [3]